SCHEMBL1815124

SCHEMBL1815124

CCOC(=O)c1nc(C(C)C)no1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.48
CYP1A2 P05177 2/20 0.39
SLC26A6 Q9BXS9 1/20 0.38
ALDH1A1 P00352 5/20 0.37
HPGD P15428 2/20 0.37
THRB P10828 1/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
CACNA1F O60840 2/20 0.36
CACNA1D Q01668 2/20 0.36
CACNA1S Q13698 2/20 0.36
CACNA1C Q13936 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13733119 0.89 HTT (0.47) HTTCYP1A2SLC26A6ALDH1A1THRB
SCHEMBL23791456 0.81 NPSR1 (0.39) HTTALDH1A1KDM4EMAPTKMT2A
SCHEMBL7400591 0.79 HTT (0.52) HTTCYP1A2SLC26A6ALDH1A1MAPT
SCHEMBL14941595 0.78 HTT (0.47) HTTCYP1A2ALDH1A1HPGDKDM4E
SCHEMBL9461101 0.76 HTT (0.50) HTTCYP1A2ALDH1A1HPGDKDM4E
SCHEMBL15284739 0.76 HTT (0.50) HTTCYP1A2ALDH1A1HPGDKDM4E
SCHEMBL13733197 0.75 HTT (0.49) HTTCYP1A2SLC26A6ALDH1A1HPGD
SCHEMBL3559987 0.75 HTT (0.49) HTTCYP1A2ALDH1A1HPGDKDM4E
SCHEMBL15932046 0.74 GPR119 (0.38) ALDH1A1GAAMAPTNPC1RAB9A
SCHEMBL17653859 0.74 SMN1; SMN2 (0.40) HTTGAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3885340-B1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2024-11-27 EP disclosed
EP-3885340-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2021-09-29 EP disclosed
US-11046713-B2 Androgen receptor modulating compounds ORION CORPORATION (FI) 2021-06-29 US disclosed
EP-3369732-B1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2021-05-26 EP disclosed
US-20200299307-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2020-09-24 US disclosed
US-10711013-B2 Androgen receptor modulating compounds ORION CORPORATION (FI) 2020-07-14 US disclosed
US-20190100536-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2019-04-04 US disclosed
US-10118933-B2 Androgen receptor modulating compounds ORION CORPORATION (FI) 2018-11-06 US disclosed
EP-3369732-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2018-09-05 EP disclosed
EP-3056485-B1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORP (FI) 2018-05-09 EP disclosed
WO-2012143599-A1 ANDROGEN RECEPTOR MODULATING CARBOXAMIDES ORION CORPORATION (FI) 2012-10-26 WO disclosed
US-20120225867-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2012-09-06 US disclosed
EP-2493858-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS Orion Corporation (FI) 2012-09-05 EP disclosed
WO-2011051540-A9 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2012-06-21 WO disclosed
WO-2011051540-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS ORION CORPORATION (FI) 2011-05-05 WO disclosed
EP-0647635-B1 Herbicidal 1,2,4-oxadiazolecarboxylic acids amides, esters or halides SHELL INT RESEARCH (NL) 1998-07-08 EP disclosed
US-5707935-A CARBOXYAMIDE SUBSTITUTED 1,2,4-OXADIAZOLES AS HERBICIDES AMERICAN CYANAMID COMPANY (US) 1998-01-13 US disclosed
US-5593946-A Oxadiazole carbonamide herbicidal compounds AMERICAN CYANAMID CO (US) 1997-01-14 US disclosed
US-5578550-A AMIDE SUBSTITUTED OXADIAZOLES FOR HERBICIDES AND ANTIGROWTH AGENTS AMERICAN CYANAMID COMPANY (US) 1996-11-26 US disclosed
EP-0647635-A1 Herbicidal 1,2,4-oxadiazolecarboxylic acids amides, esters or halides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1995-04-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10118933-B2 Androgen receptor modulating compounds AR, NR5A1, SHBG HTT 4286/4885CYP1A2 316/4885SLC26A6 1684/4885
US-10711013-B2 Androgen receptor modulating compounds AR, NR5A1, SHBG HTT 4286/4885CYP1A2 316/4885SLC26A6 1684/4885
US-20200299307-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS AR, NR5A1, SHBG HTT 4286/4885CYP1A2 316/4885SLC26A6 1684/4885
US-20190100536-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS AR, NR5A1, SHBG HTT 4286/4885CYP1A2 316/4885SLC26A6 1684/4885
US-11046713-B2 Androgen receptor modulating compounds AR, NR5A1, SHBG HTT 4286/4885CYP1A2 316/4885SLC26A6 1684/4885
US-20120225867-A1 ANDROGEN RECEPTOR MODULATING COMPOUNDS AR, NR5A1, SHBG HTT 4286/4885CYP1A2 316/4885SLC26A6 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.